Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis

by Amit Roy, Randall J. Brenneman, Jacob Hogan, Justin M. Barnes, Yi Huang, Robert Morris, Sreekrishna Goddu, Michael Altman, Jose Garcia-Ramirez, Harold Li, Jacqueline E. Zoberi, Arnold Bullock, Eric Kim, Zachary Smith, Robert Figenshau, Gerald L. Andriole, Brian C. Baumann, Jeff M. Michalski, Hiram A. Gay
Published 2021-07-01